Nakken Karl O, Johannessen Svein I
Epilepsisenteret-SSE, Sandvika, Posboks 53, 1306 Baerum postterminal.
Tidsskr Nor Laegeforen. 2008 Sep 25;128(18):2052-5.
In certain types of epilepsy, antiepileptic drugs can exacerbate the disease instead of improving it.
This review is based on a non-systematic literature search in Medline for the time-period 1990-2007, and our own clinical experience.
As a consequence of treatment with antiepileptic drugs, patients with epilepsy may have more frequent and severe seizures of the type they had before, but also new seizure types or patterns, and even series of seizures or status epilepticus. Both old and new antiepileptic drugs may exacerbate seizures, but carbamazepine-induced generalized seizures (such as absence and myoclonic) are best documented. More than one pathophysiological mechanism is probably involved in drug-related exacerbation of seizures, such as sedative and pro-convulsive effects of high serum levels, drug-associated encephalopathy, and a paradoxical pharmacodynamic effect. Accurate epilepsy- and seizure classification is important in the treatment of all types of epilepsy. Atypical absences are sometimes mistaken for complex partial seizures. Such patients may be given drugs with a narrow spectrum such as sodium channel blockers (e.g. carbamazepine, phenytoin, oxcarbazepine) or GABAergic agents (e.g. vigabatrin, tiagabine) with an increased risk of seizure exacerbation. Those at greatest risk of experiencing drug-related seizure exacerbation are learning-disabled patients, children with severe epileptic encephalopathies, those with high seizure frequency and several seizure types, and those using polytherapy.
在某些类型的癫痫中,抗癫痫药物可能会使病情恶化而非改善。
本综述基于1990年至2007年期间在Medline进行的非系统性文献检索以及我们自己的临床经验。
使用抗癫痫药物治疗后,癫痫患者可能会出现比之前更频繁、更严重的原有类型发作,还可能出现新的发作类型或模式,甚至出现一连串发作或癫痫持续状态。新旧抗癫痫药物都可能加剧发作,但卡马西平诱发的全身性发作(如失神发作和肌阵挛发作)记录最为详尽。药物相关的发作加剧可能涉及多种病理生理机制,如高血清水平的镇静和促惊厥作用、药物相关性脑病以及矛盾的药效学效应。准确的癫痫和发作分类在所有类型癫痫的治疗中都很重要。非典型失神发作有时会被误诊为复杂部分性发作。这类患者可能会使用作用谱较窄的药物,如钠通道阻滞剂(如卡马西平、苯妥英、奥卡西平)或γ-氨基丁酸能药物(如氨己烯酸、噻加宾),从而增加发作加剧的风险。癫痫发作加剧风险最高的人群包括有学习障碍的患者、患有严重癫痫性脑病的儿童、发作频率高且发作类型多样的患者以及接受联合治疗的患者。